NewsSource: EClinCloud

Invitation | EClinCloud Invites You to the Medical Equipment Exhibition to Discuss Digital Enablement for Medical Device Clinical Trials

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image

The China Medical Equipment Conference & 2023 Medical Equipment Exhibition will be held April 25–28, 2023, in Chongqing.


Themed "Integrating Medicine and Engineering: Writing a New Chapter of Innovation and Development," the conference focuses on medical equipment technological innovation, industry development, and clinical application. It will analyze relevant policies, explore industry development trends, showcase the latest technologies, exchange insights on discipline building, share practical experience, promote the safe and effective application of medical equipment, and advance high-quality industry development.


As a promoter of digital clinical trials in China, EClinCloud has been committed to empowering medical device clinical trials through technological innovation, integrating digital management concepts into every stage of device clinical trials, and using information technology to improve trial quality and accelerate the market launch process for medical device products. We welcome you to visit the EClinCloud booth and discuss the future together!



 Exhibition Information 


Exhibition Dates:

April 25–28, 2023


Exhibition Venue:

Chongqing International Expo Center, Halls N1, N2, N3, N4, and N5

Address: 66 Yuelai Avenue, Yubei District, Chongqing


Organizer:

China Association of Medical Equipment



“

EClinCloud Booth


Booth Number: Hall N4, F27


Article image



Special Gifts



We have prepared a lucky draw with a 100% win rate and special gifts for you at our booth. We look forward to seeing you there!

Article image
Xiaomi Speaker
Article image
Travel Toiletry Bag
Article image
Felt Bag




“

Registration Portal

Article image


EClinCloud Cordially Invites You to Attend the Exhibition

We look forward to meeting you on-site

to exchange ideas on new technologies and concepts

We will be at Hall N4, Booth F27

See you there!







About EClinCloud

EClinCloud is a technology company focused on clinical R&D, offering an integrated, interconnected all-in-one cloud platform for clinical trials (including technology products such as eCOA, CTMS, eTMF, EDC, and RTSM, and solutions such as scale management, linguistic validation, rater training, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, and ophthalmology). By combining cutting-edge technology with life sciences data to build a globally leading, "patient-centric" SaaS cloud platform supporting clinical evidence, EClinCloud helps domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.




Article image

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.